Co-Diagnostics Receives Logix Smart ZDC Test Order from Peru Distributor as Dengue Cases Rise and Exhibits at MEDICA 2026 in Dusseldorf
Nov 17, 2026, 9:40 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The disclosed distributor order and study shipments are concrete commercial demand that could translate into incremental near-term product revenue and instrument sales; the magnitude and recurrence are unspecified, so revenue impact is conditional on order size and follow-on demand.
AI summary
What happened, with direct paths to the underlying reporting
Co-Diagnostics announced a new order from its Peru distributor for the Logix Smart ZDC test and shipments of tests for a study in Bolivia; it also noted ~17 PCR instruments shipped to Bolivia since early 2025.
The company's distributor in Peru placed a new order for the Logix Smart® ZDC test amid rising dengue activity.
Logix Smart® ZDC tests were shipped to be used by a European organization in a study in Bolivia.
Co-Dx has supplied approximately 17 real-time PCR instruments to its distributor in Bolivia since the beginning of 2025.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Co-Diagnostics has initiated shipments for tuberculosis (TB) test studies in India, expanding its market reach across South Asia through a new partnership. This move aligns with W…
Co-Diagnostics (CODX) has expanded its market presence in South Asia, increasing its total addressable market to $13 billion. This strategic move supports its goal of commercializ…
CODX withdrew its FDA 510(k) application due to shelf‐life stability concerns. An enhanced COVID-19 test version will be submitted after additional clinical data is collected. The…